2013 Tumor Markers and Special Chemistry Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan
US$ 6,800.00
... Hemoglobin HCG 25-Hydroxy Vitamin D2 and D3 Occult Blood PAP PSA Thyroglobulin Vitamin B-12 During the next decade, the tumor markers and ... as specimen preparation devices, controls, calibrators and others. “2013 Tumor Markers and Special Chemistry Testing Market: US, Europe (France, Germany, Italy, ...
May 2013
320 pages
CompetitiveWatch Cancer Diagnostics: Strategic Assessments of Major Suppliers
US$ 2,000.00
This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 80 pages
May 2013
80 pages
2013 Analysis of the French Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 4,880.00
Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 585-page analysis of the French tumor marker testing market. Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and ...
April 2013
585 pages
2013 Analysis of the Italian Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 4,880.00
Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 570-page analysis of the Italian tumor marker testing market. Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and ...
April 2013
570 pages
2013 Analysis of the German Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 4,880.00
Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 585-page analysis of the German tumor marker testing market. Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and ...
April 2013
585 pages
2013 Analysis of the Japanese Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 6,000.00
Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $2,450. Highlights Comprehensive 590-page analysis of the Japanese tumor marker testing market. Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and ...
April 2013
590 pages
2013 Analysis of the Spanish Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 4,880.00
Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 565-page analysis of the Spanish tumor marker testing market. Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and ...
April 2013
565 pages
2013 Analysis of the UK Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 4,880.00
Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 575-page analysis of the UK tumor marker testing market. Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological ...
April 2013
575 pages
2013 Analysis of the US Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 7,760.00
Complete report $8,700. DataPack (test volumes, sales forecasts, supplier shares) $3,450. Highlights Comprehensive 620-page analysis of the US tumor marker testing market. Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological ...
April 2013
620 pages
2013 Analysis of the French Cancer Diagnostics Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 4,880.00
This report presents a comprehensive analysis of the French cancer diagnostics market, including: Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2013
585 pages
2013 Analysis of the German Cancer Diagnostics Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 4,880.00
This report presents a comprehensive analysis of the German cancer diagnostics market, including: Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2013
585 pages
2013 Analysis of the Italian Cancer Diagnostics Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 4,880.00
This report presents a comprehensive analysis of the Italian cancer diagnostics market, including: Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2013
570 pages
2013 Analysis of the Japanese Cancer Diagnostics Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 6,080.00
This report presents a comprehensive analysis of the Japanese cancer diagnostics market, including: Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...
April 2013
590 pages
2013 Analysis of the Spanish Cancer Diagnostics Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 4,880.00
This report presents a comprehensive analysis of the Spanish cancer diagnostics market, including: Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2013
565 pages
2013 Analysis of the UK Cancer Diagnostics Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 4,880.00
This report presents a comprehensive analysis of the UK cancer diagnostics market, including: Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2013
620 pages
2013 Analysis of the US Cancer Diagnostics Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 7,840.00
This report presents a comprehensive analysis of the US cancer diagnostics market, including: Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2013
620 pages
2013 Analysis of the European Cancer Diagnostics Market: France, Germany, Italy, Spain, UK Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 15,760.00
... new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the European cancer diagnostic testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for ...
April 2013
320 pages
2013 Analysis of the European Tumor Marker Testing Market: France, Germany, Italy, Spain, UK Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 15,760.00
... new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the European cancer diagnostic testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for ...
April 2013
820 pages
Cancer Testing in Europe: Market Segment Forecasts and Supplier Shares
US$ 15,760.00
... other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and evaluates major ... disease. During the next five years, the European cancer diagnostic testing market is promising to be an exciting, dynamic and rapidly expanding field. ...
March 2013
820 pages
Competing in the European Cancer Diagnostics Market: France, Germany, Italy, Spain, UK
US$ 15,760.00
... Planning Group identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends in ... basis of the disease. During the next five years, the European cancer diagnostic testing market is promising to be an exciting, dynamic and rapidly ...
February 2013
820 pages
Competing in the US Cancer Diagnostics Market
US$ 7,840.00
... trends with significant market impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. Five- ...
February 2013
620 pages
Emerging Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers
US$ 10,000.00
... Review of the emerging POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. Five-year test volume ... coagulation procedures by market segment: Cancer Clinics Ambulatory Care Centers Surgery Centers Nursing Homes Birth Centers and by test category: Routine ...
February 2013
1007 pages
2013 French Hospital Cancer Diagnostics Market
US$ 3,080.00
This new report from Venture Planning Group contains 533 pages, 43 tables, and presents a comprehensive analysis of the French hospital cancer diagnostics market, including: Major issues pertaining to the French hospital laboratory practice, as well as key economic, ...
December 2012
533 pages
2013 German Hospital Cancer Diagnostics Market
US$ 3,080.00
This new report from Venture Planning Group contains 533 pages, 40 tables, and presents a comprehensive analysis of the German hospital cancer diagnostics market, including: Major issues pertaining to the German hospital laboratory practice, as well as key economic, ...
December 2012
533 pages
2013 Italian Hospital Cancer Diagnostics Market
US$ 3,080.00
This new report from Venture Planning Group contains 525 pages, 38 tables, and presents a comprehensive analysis of the Italian hospital cancer diagnostics market, including: Major issues pertaining to the Italian hospital laboratory practice, as well as key ...
December 2012
525 pages
2013 Japanese Hospital Cancer Diagnostics Market
US$ 3,880.00
This new report from Venture Planning Group contains 537 pages, 42 tables, and presents a comprehensive analysis of the Japanese hospital cancer diagnostics market, including: Major issues pertaining to the Japanese hospital laboratory practice, as well as key ...
December 2012
537 pages
2013 Spanish Hospital Cancer Diagnostics Market
US$ 3,080.00
This new report from Venture Planning Group contains 521 pages, 41 tables, and presents a comprehensive analysis of the Spanish hospital cancer diagnostics market, including: Major issues pertaining to the Spanish hospital laboratory practice, as well as key ...
December 2012
521 pages
2013 UK Hospital Cancer Diagnostics Market
US$ 3,080.00
This new report from Venture Planning Group contains 527 pages, 37 tables, and presents a comprehensive analysis of the UK hospital cancer diagnostics market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...
December 2012
527 pages
2013 US Hospital Cancer Diagnostics Market
US$ 5,200.00
This new report from Venture Planning Group contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital cancer diagnostics market, including: Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends ...
December 2012
567 pages
2013 France Tumor Marker Testing Market: Opportunities and Strategies for Suppliers
US$ 4,320.00
Highlights This new 585-page analysis of the French tumor marker testing market report from Venture Planning Group including: Major ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...
December 2012
585 pages
2013 Italy Tumor Marker Testing Market: Opportunities and Strategies for Suppliers
US$ 4,320.00
Highlights This new 570-page analysis of the Italian tumor marker testing market report from Venture Planning Group including: Major ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...
December 2012
570 pages
2013 Germany Tumor Marker Testing Market: Opportunities and Strategies for Suppliers
US$ 4,320.00
Highlights This new 585-page analysis of the German tumor marker testing market report from Venture Planning Group including: Major ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...
December 2012
585 pages
2013 Japan Tumor Marker Testing Market: Opportunities and Strategies for Suppliers
US$ 5,360.00
Highlights This new 590-page analysis of the Japanese tumor marker testing market report from Venture Planning Group including: Major ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...
December 2012
590 pages
2013 Spain Tumor Marker Testing Market: Opportunities and Strategies for Suppliers
US$ 4,320.00
Highlights This new 565-page analysis of the Spanish tumor marker testing market report from Venture Planning Group including: Major ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...
December 2012
595 pages
2013 UK Tumor Marker Testing Market: Opportunities and Strategies for Suppliers
US$ 4,320.00
Highlights This new 575-page analysis of the UK tumor marker testing market report from Venture Planning Group including: Major issues ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...
December 2012
575 pages
2013 US Tumor Marker Testing Market: Opportunities and Strategies for Suppliers
US$ 6,960.00
Highlights This new 620-page analysis of the US tumor marker testing market report from Venture Planning Group including: Major issues ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...
December 2012
620 pages
UK Tumor Marker Testing Market: Innovative Technologies and Emerging Business Opportunities
US$ 4,320.00
Highlights Comprehensive 575-page analysis of the UK tumor marker testing market. Major issues pertaining to the UK laboratory practice, as well as key economic, ... , lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for 40 ...
December 2012
575 pages
US Tumor Marker Testing Market: Innovative Technologies and Emerging Business Opportunities
US$ 6,960.00
Highlights Comprehensive 620-page analysis of the US tumor marker testing market. Major issues pertaining to the US laboratory practice, as well as key economic, ... , lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for 40 ...
December 2012
620 pages